Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Tilly's
TLYS
$121M
| $17.2M | 0.01% |
1,820,454
+542,854
| +42% | +$4.79M |
|
1052
Lockheed Martin
LMT
$140B
| $17.2M | 0.01% |
43,991
+36,891
| +520% | +$13.9M |
|
1053
Gibraltar Industries
ROCK
$1.46B
| $17.2M | 0.01% |
373,404
+69,004
| +23% | +$2.89M |
|
1054
Pilgrim's Pride
PPC
$6.4B
| $17.1M | 0.01% |
534,713
+477,900
| +841% | +$13.9M |
|
1055
Insulet
PODD
$10.1B
| $17.1M | 0.01% |
103,700
-39,700
| -28% | -$5.58M |
|
1056
Hanmi Financial
HAFC
$956M
| $17.1M | 0.01% |
908,757
+14,200
| +2% | +$280K |
|
1057
Phibro Animal Health
PAHC
$1.37B
| $16.9M | 0.01% |
794,500
+38,000
| +5% | +$1.04M |
|
|
FBM
1058
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $16.9M | 0.01% |
1,093,000
+556,812
| +104% | +$9.66M |
|
1059
Camtek
CAMT
$8.13B
| $16.8M | 0.01% |
1,794,680
-138,785
| -7% | -$1.27M |
|
|
CORE
1060
DELISTED
Core Mark Holding Co., Inc.
CORE
| $16.8M | 0.01% |
523,592
+103,190
| +25% | +$3.59M |
|
|
MNTA
1061
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $16.8M | 0.01% |
1,297,486
-319,804
| -20% | -$3.86M |
|
1062
Roper Technologies
ROP
$39.1B
| $16.7M | 0.01% |
46,900
-139,600
| -75% | -$50.7M |
|
|
IBTX
1063
DELISTED
Independent Bank Group, Inc.
IBTX
| $16.7M | 0.01% |
317,809
+46,800
| +17% | +$2.47M |
|
|
SLCA
1064
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $16.7M | 0.01% |
1,744,012
+942,212
| +118% | +$10.9M |
|
1065
Ameriprise Financial
AMP
$49.9B
| $16.7M | 0.01% |
113,300
+101,900
| +894% | +$14.3M |
|
|
PMT
1066
PennyMac Mortgage Investment
PMT
$827M
| $16.7M | 0.01% |
749,200
+393,300
| +111% | +$8.67M |
|
1067
Western New England Bancorp
WNEB
$282M
| $16.6M | 0.01% |
1,740,627
+27,300
| +2% | +$251K |
|
|
LTRPA
1068
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $16.5M | 0.01% |
1,756,721
+124,700
| +8% | +$1.3M |
|
|
VLRS
1069
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $16.5M | 0.01% |
1,649,700
+259,000
| +19% | +$2.49M |
|
1070
Glaukos
GKOS
$11.2B
| $16.5M | 0.01% |
264,100
+89,700
| +51% | +$6.32M |
|
1071
Peoples Bancorp
PEBO
$1.48B
| $16.5M | 0.01% |
518,879
+700
| +0.1% | +$22.2K |
|
1072
Stoneridge
SRI
$197M
| $16.4M | 0.01% |
530,919
-42,000
| -7% | -$1.32M |
|
1073
SLM Corp
SLM
$5.26B
| $16.4M | 0.01% |
1,861,200
-1,413,500
| -43% | -$12.7M |
|
1074
Pediatrix Medical
MD
$2.15B
| $16.4M | 0.01% |
725,300
-31,100
| -4% | -$709K |
|
1075
Integra LifeSciences
IART
$1.35B
| $16.4M | 0.01% |
273,060
+180,300
| +194% | +$10.7M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.